StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) bonds

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)

Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Integra LifeSciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Integra LifeSciences's 10-Q for the period ended Sep 30, 2026

IssueCoupon
2025 Notes
Convertible at $74 a share
0.50%

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Revolving Credit Facility$1.30B
Senior Credit Facility$2.10B
Standby Letters of Credit$60.00M
Swingline Loan$60.00M
Swingline Loans$60.00M
Term Loan Facility$775.00M

See a number that looks wrong?